#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Leukaemia Paroxysmal nocturnal haemoglobinuria Asthma Solitary fibrous tumour Wolfram syndrome Mycobacterium abscessus infection Tuberous sclerosis complex Congenital cystic kidney disease Demyelination Adrenoleukodystrophy Methylmalonic acidaemia Pelizaeus-Merzbacher disease Primary hyperoxaluria Infertility male More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Trials in Disease Behcet’s syndrome – Diagnostics Ewing’s sarcoma – Trials in Disease Proteus syndrome – Trials in Disease Optic glioma – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Treatment Retinitis pigmentosa – Treatment Paraneoplastic neurological syndrome – Diagnostics Niemann-Pick disease – Treatment Lymphatic malformation – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sucrose Azd3470 Amsacrine Ly3871801 Tacrolimus Efmoroctocog Alfa Deferoxamine Mesilate Pitolisant Dextrose Bp L-SERINE VAMIFEPORT TRIHYDROCHLORIDE Tigulixostat Betibeglogene Autotemcel Bms-986408 Abiraterone Clonidine Hydrochloride Azd9550 Pegunigalsidase Alfa Gsk3858279 CIRTUVIVINT More therapies…

    Learn about Your Condition

    Tuberculosis Diabetic autonomic neuropathy Liposarcoma recurrent Perinatal depression Metastases to biliary tract Orthostatic hypotension Renal failure Systemic sclerosis pulmonary Osteonecrosis of jaw Toxic nodular goitre Pancreatic carcinoma stage IV Ewing's sarcoma recurrent Small fibre neuropathy Vitamin D deficiency Myopia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma unspecified histology aggressive
    • Marginal zone lymphoma
    • B-cell lymphoma
    Investigated Drugs:
    • Odronextamab
    France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Vonicog Alfa with or without Octocog Alfa for Children with Severe von Willebrand Disease Experiencing Bleeding or Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Von Willebrand’s disease
    Investigated Drugs:
    • Octocog Alfa
    • Vonicog Alfa
    Austria Belgium France Italy Spain

  • Study on REGN7508 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Enoxaparin Sodium
    Bulgaria Hungary Latvia Lithuania Poland

  • Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Fitusiran
    Italy Spain

  • Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Tamibarotene
    • Azacitidine
    Austria Belgium Czechia France Germany Hungary +3

  • Study on Osimertinib for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Osimertinib
    • Placebo
    Spain
Previous Page
1 … 70 71 72 73 74 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!